Editorial Staff

Amar Sawhney on Sikhs, STEM & COVID

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

The entrepreneurial spirit among immigrants and refugees allows them the flexibility to pursue unexpected courses of action, adapt, accept risk and make the most of opportunities they didn’t even know of before. For Dr. Amar Sawhney from India, that started at the University of Texas at Austin with 30 job rejections out of 30 applications. But he charted a path that would see him go in directions hitherto unknown to him: getting a PhD, helping found a company, journeying to Boston, and starting a string of new companies, using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue. He’s been named a “Champion of Change” by The White House, one of the “five most innovative Medical Device CEOs” by MassDevice, the EY regional entrepreneur of the year, The Immigrant Learning Center’s own Immigrant Entrepreneur Awardee for Life Science Business. But his influence extends well beyond that space into environmental conservationism, safeguarding refugees, mentoring and promoting STEM education, and building public understanding of America’s Sikhs, as you’ll hear in this week’s episode of JobMakers.

Guest:

Amarpreet Sawhney, Ph.D., is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions. Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc. (acquired by Boston Scientific), Founder and CEO of Confluent Surgical (acquired by Covidien), the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. (acquired by Cardinal Health). He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of EcoSikh, Axtria, Imperative care, Instylla, Rejoni, Tulavi, and Incept LLC. He is on the advisory board of the MIT museum. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

Get new episodes of JobMakers in your inbox!

Browse recent episodes of Pioneer podcasts:

UVA Law Professor Kimberly Robinson On Legal Debate About Education As Federal Right

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Kimberly Robinson, Professor at the University of Virginia School of Law and the Curry School of Education, about her new book, "A Federal Right to Education: Fundamental Questions for Our Democracy," and the need for states to establish a “floor of opportunity” to ensure educational equity.

Conquering COVID-19: When and From Where Will Vaccines and Therapies Emerge?

0 Comments
/
This week on Hubwonk, Host Joe Selvaggi is joined by Pioneer’s Bill Smith, Visiting Fellow in Life Sciences, and Dr. Peter Kolchinsky, Harvard-trained virologist, biotech investor and author of the new book, The Great American Drug Deal, to learn how the SARS-CoV2 works, what a vaccine may look like, and how we might produce it to scale.

New York Times #1 best-selling author John M. Barry on the 1918 Influenza Pandemic & lessons for COVID-19

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by John M. Barry, author of the #1 New York Times best seller, The Great Influenza: The Story of the Deadliest Pandemic in History.

A Tipping Point for Telehealth – Bringing Healthcare into Your Home

0 Comments
/
This week on "Hubwonk," Joe Selvaggi and Josh Archambault talk with Dr. Roy Schoenberg, Chief Executive of Amwell, a global telehealth technology company headquartered in Boston, about the promise of telemedicine and how the COVID-19 pandemic has catalyzed broader adoption.

Ashley Berner of Johns Hopkins on Academic Quality, Educational Pluralism, & the Providence Public Schools

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Ashley Berner, Deputy Director of the Johns Hopkins Institute for Education Policy. 

Coronavirus & Contracts – Protecting Massachusetts Attorneys & Clients from Risk

0 Comments
/
In this episode of "Hubwonk," host Joe Selvaggi and Pioneer’s Chief Financial Officer & Director of Government Transparency, Mary Connaughton, speak with attorney and entrepreneur Kosta Ligris about how Massachusetts’ requirement for live attestation for many vital contracts is putting attorneys and clients at risk of exposure to coronavirus.

Buoy Health – Intelligent Front Door to Optimized Healthcare

0 Comments
/
In this first episode of Pioneer's new podcast, Hubwonk, host Joe Selvaggi and Pioneer Senior Fellow in Healthcare Josh Archambault talk with Dr. Andrew Le, cofounder and Chief Executive Officer of Buoy Health.

Christensen Institute Co-founder Michael Horn on Digital Learning & COVID-19

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Michael Horn, co-founder of the Clayton Christensen Institute for Disruptive Innovation.

Pioneer Institute Launches Its New Policy Podcast, “HubWonk”

Pioneer Institute is pleased to announce the launch today of a new, weekly podcast called “HubWonk,” covering timely topics, with insights and in-depth interviews on the issues that affect our quality of life, ability to prosper, and liberties. 

The Institute for Justice’s Tim Keller on Espinoza v. Montana DOR & ongoing school choice litigation

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Tim Keller, Senior Attorney with the Institute for Justice, which is representing the plaintiffs in the high-profile Espinoza v. Montana Department of Revenue case currently before the U.S. Supreme Court,.

Stanford Pulitzer Winner David Kennedy on Lessons for COVID-19 from the 1918 Flu Epidemic & Great Depression

0 Comments
/
This week on “The Learning Curve” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Pulitzer-winning historian David Kennedy, the Donald J. McLachlan Professor of History Emeritus at Stanford University.

The Washington Post’s Jay Mathews on schooling during COVID-19 & lessons from teaching great Jaime Escalante

0 Comments
/
This week on “The Learning Curve,” Cara and Gerard continue coverage of COVID-19’s impact on K-12 education, joined by Jay Mathews, Washington Post education columnist.